BRTX
Price:
$1.5
Market Cap:
$10.38M
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (Therm...[Read more]
Industry
Biotechnology
IPO Date
2012-12-05
Stock Exchange
NASDAQ
Ticker
BRTX
According to BioRestorative Therapies, Inc.’s latest financial reports and current stock price. The company's current ROE is -42.90%. This represents a change of 312.89% compared to the average of -10.39% of the last 4 quarters.
The mean historical ROE of BioRestorative Therapies, Inc. over the last ten years is 144.37%. The current -42.90% ROE has changed -129.72% with respect to the historical average. Over the past ten years (40 quarters), BRTX's ROE was at its highest in in the March 2021 quarter at 580.96%. The ROE was at its lowest in in the December 2021 quarter at -94.47%.
Average
144.37%
Median
139.21%
Minimum
-138.62%
Maximum
920.37%
Discovering the peaks and valleys of BioRestorative Therapies, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 556.14%
Maximum Annual ROE = 920.37%
Minimum Annual Increase = -115.06%
Minimum Annual ROE = -138.62%
Year | ROE | Change |
---|---|---|
2023 | -104.13% | -8.49% |
2022 | -113.79% | -17.91% |
2021 | -138.62% | -115.06% |
2020 | 920.37% | 556.14% |
2019 | 140.27% | -3.17% |
2018 | 144.86% | 4.86% |
2017 | 138.15% | -20.01% |
2016 | 172.72% | -14.80% |
2015 | 202.73% | 149.92% |
2014 | 81.12% | -5.71% |
The current ROE of BioRestorative Therapies, Inc. (BRTX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-118.85%
5-year avg
140.82%
10-year avg
144.37%
BioRestorative Therapies, Inc.’s ROE is greater than Pulmatrix, Inc. (-61.78%), greater than Capricor Therapeutics, Inc. (-220.26%), less than Akari Therapeutics, Plc (1.04%), greater than Diffusion Pharmaceuticals Inc. (-55460.19%), greater than Soleno Therapeutics, Inc. (-43.25%), less than Propanc Biopharma, Inc. (63.02%), greater than Cadrenal Therapeutics, Inc. Common Stock (-93.71%), greater than Bonus BioGroup Ltd. (-112.89%), greater than InVivo Therapeutics Holdings Corp. (-72.27%), less than Cingulate Inc. (11.47%), greater than SAB Biotherapeutics, Inc. (-94.04%), greater than Anebulo Pharmaceuticals, Inc. (-138.92%), greater than Monopar Therapeutics Inc. (-110.60%), greater than Can-Fite BioPharma Ltd. (-179.39%), greater than Candel Therapeutics, Inc. (-629.29%), greater than XTL Biopharmaceuticals Ltd. (-14.91%), less than Cingulate Inc. (11.47%), greater than Achieve Life Sciences, Inc. (-116.78%), greater than Bio-Path Holdings, Inc. (-2842.40%), greater than Icosavax, Inc. (-41.24%),
Company | ROE | Market cap |
---|---|---|
-61.78% | $7.59M | |
-220.26% | $845.38M | |
1.04% | $29.50M | |
-55460.19% | $8.98M | |
-43.25% | $2.18B | |
63.02% | $180.86K | |
-93.71% | $15.24M | |
-112.89% | $23.36M | |
-72.27% | $995.92K | |
11.47% | $11.86M | |
-94.04% | $37.29M | |
-138.92% | $49.01M | |
-110.60% | $87.22M | |
-179.39% | $15.23M | |
-629.29% | $166.52M | |
-14.91% | $17.41M | |
11.47% | $11.66M | |
-116.78% | $162.78M | |
-2842.40% | $3.61M | |
-41.24% | $769.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioRestorative Therapies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioRestorative Therapies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioRestorative Therapies, Inc.'s ROE?
How is the ROE calculated for BioRestorative Therapies, Inc. (BRTX)?
What is the highest ROE for BioRestorative Therapies, Inc. (BRTX)?
What is the 3-year average ROE for BioRestorative Therapies, Inc. (BRTX)?
What is the 5-year average ROE for BioRestorative Therapies, Inc. (BRTX)?
How does the current ROE for BioRestorative Therapies, Inc. (BRTX) compare to its historical average?